CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.36 CNY | -0.71% |
|
+0.45% | -26.59% |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
| Apr. 02 | Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. | CI |
| Sales 2023 | 2.11B 292M | Sales 2024 * | - | Capitalization | 23.55B 3.25B |
|---|---|---|---|---|---|
| Net income 2023 | 367M 50.65M | Net income 2024 * | - | EV / Sales 2023 | 15.2 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 |
87.3
x | P/E ratio 2024 * |
-
| Employees | 2,324 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 32.82% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.71% | ||
| 1 week | +4.02% | ||
| Current month | -8.56% | ||
| 1 month | -7.85% | ||
| 3 months | -10.47% | ||
| 6 months | -20.17% | ||
| Current year | -26.59% |
1 week
39.47
41.44
1 month
37.5044.66
Current year
37.5055.53
1 year
37.5067.00
3 years
37.50137.14
5 years
37.50141.43
10 years
37.50141.43
| Managers | Title | Age | Since |
|---|---|---|---|
Xiu Cai Liu
CHM | Chairman | 67 | 19-08-17 |
Wen Ying Yang
DFI | Director of Finance/CFO | - | - |
Chen Yang
COO | Chief Operating Officer | 40 | 19-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
William Keller
BRD | Director/Board Member | 75 | 19-08-17 |
Joachim Rudolf
BRD | Director/Board Member | 63 | 19-08-17 |
Xiu Cai Liu
CHM | Chairman | 67 | 19-08-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -12.28% | - | |
| 0.81% | 45 M€ | -16.38% | - | |
| 0.81% | 45 M€ | -14.97% | - | |
| 0.81% | 39 M€ | -14.72% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 40.36 | -0.71% | 835,539 |
| 24-04-23 | 40.65 | -0.15% | 960,149 |
| 24-04-22 | 40.71 | +1.47% | 1,345,470 |
| 24-04-19 | 40.12 | +0.60% | 1,079,829 |
| 24-04-18 | 39.88 | -0.75% | 1,155,170 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.59% | 3.27B | |
| +4.53% | 25.89B | |
| +11.44% | 1.75B | |
| -27.06% | 374M | |
| -81.65% | 216M | |
| -9.88% | 115M | |
| -14.86% | 50.83M |
- Stock Market
- Equities
- 688065 Stock
